Optimizing Patient Engagement in a Novel Pain Management Initiative (OPEN)

NCT02136108 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 197

Last updated 2018-04-18

No results posted yet for this study

Summary

The OPEN study has two aims: The first is to identify what helps to keep patients involved with a Medicaid chronic pain management program and to identify features of an ideal text-message-based program for people enrolled in the program. The second aim is to develop the text-message-based program (OPENtext), then find out how useful this intervention is compared to a patient navigator intervention (OPENnav) for increasing patient engagement, improving patient's motivation to manage their chronic pain, and improving patient confidence in self-managing their chronic pain condition.

Conditions

Interventions

OTHER

OPENtext

Participants will receive 12 weeks of daily text messages sent from an automated system. The text messages will assist participants in managing their chronic pain.

OTHER

OPENnav

Particpants will be linked with a RIPN PEER Navigator who will assisted them in managing their health care

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER
  • Lifespan

    collaborator OTHER
  • Rhode Island Hospital

    collaborator OTHER
  • The Miriam Hospital

    collaborator OTHER
  • Inflexxion, Inc.

    lead INDUSTRY

Principal Investigators

  • Traci Green, PhD, MSc · Inflexxion, Inc., Brown University, and Rhode Island Hospital

  • Megan Ranney, MD · The Miriam Hospital and Brown University

  • Elizabeth Donovan, PhD · Independent Consultant

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-01
Primary Completion
2017-09-14
Completion
2018-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02136108 on ClinicalTrials.gov